Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile-Reference-Cited by-同舟云学术

Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile

Published:2011-08-01 Issue:8 Volume:60 Page:1206-1212
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Huhulescu Steliana¹,Sagel Ulrich¹,Fiedler Anita¹,Pecavar Verena¹,Blaschitz Marion¹,Wewalka Guenther¹,Allerberger Franz²,Indra Alexander²

Affiliation:

1. Austrian Agency for Health and Food Safety (AGES), Institute for Medical Microbiology, Hygiene, Waehringerstrasse 25a, A-1096 Vienna, Austria

2. Paracelsus Medical University, Institute for Medical Microbiology, Hygiene and Infectious Diseases, Muellner Hauptstrasse 48, A-5020 Salzburg, Austria

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference22 articles.

1. Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin;Corazza;J Int Med Res,1988

2. Clinical impact of rapid in vitro susceptibility testing and bacterial identification;Doern;J Clin Microbiol,1994

3. Breakpoint tables for interpretation of MICs and zone diameters, Version 1.1,2010

4. Treatment of hepatic encephalopathy with non-absorbable antibiotics;Festi;Ital J Gastroenterol,1992

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review;Clinical Microbiology Reviews;2023-12-20

2. Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019–2021;Journal of Microbiology, Immunology and Infection;2023-12

3. Molecular epidemiology and clinical risk factors for rifaximin-non-susceptible Clostridioides difficile infection in South Korea: a prospective, multicentre, observational study;Journal of Global Antimicrobial Resistance;2021-12

4. Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria In Vitro;mSystems;2020-02-11

5. A Call to Action: the Need for Standardization in Developing Open-Source Mass Spectrometry-Based Methods for Microbial Subspecies Discrimination;mSystems;2020-02-11